Role of staging laparoscopy for gastric cancer patients
- PMID: 31549009
- PMCID: PMC6749947
- DOI: 10.1002/ags3.12283
Role of staging laparoscopy for gastric cancer patients
Abstract
Staging laparoscopy (SL) is frequently carried out in patients with advanced gastric cancer. However, some clinical questions are being debated and consensus must be obtained. With this aim, a literature search of PubMed/MEDLINE was carried out using the keywords "gastric cancer," "SL," and "diagnostic laparoscopy". Articles published online up to February 2019 were analyzed, focusing on the following questions. (i) What is an adequate indication for SL? (ii) How do you carry out SL? (iii) Does SL provide accurate information about peritoneal dissemination? (iv) Is the yield of SL different by tumor location? (v) Is SL a safe procedure? (vi) Is "repeat SL" needed? (vii) Does SL provide oncological benefit? Results provided the following responses: (i) In Western countries, clinically resectable advanced tumor is an indication for SL. Terms to be introduced for adequate indication include "location," "type 4 (linitis feature)," "large tumor," "equivocal computed tomography (CT] findings," and "lymph node swelling". (ii) Exploration of the entire peritoneal cavity is preferable. (iii) Detection rate of peritoneal disease is 43%-52% in Japanese institutions and 7.8%-40% in other countries. False-negative findings during SL were 0%-17%, and 10%-13% when limited to cytology. (iv) Yield of SL was higher in gastric cancer compared with esophagogastric junctional tumor. (v) SL-related complications were estimated to occur in 0.4%. (vi) Repeat SL is important after treatment. (vii) If the efficacy of neoadjuvant chemotherapy for patients with P0CY1 is established, SL can provide oncological benefit. SL can be carried out safely and effectively. Considering the prevalence of neoadjuvant treatment, the role of SL will become more important.
Keywords: chemotherapy; gastric cancer; laparoscopy; peritoneal dissemination; staging.
Figures


Similar articles
-
[Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):170-176. doi: 10.3760/cma.j.issn.1671-0274.2020.02.013. Zhonghua Wei Chang Wai Ke Za Zhi. 2020. PMID: 32074798 Clinical Trial. Chinese.
-
Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.Gastric Cancer. 2020 Mar;23(2):319-327. doi: 10.1007/s10120-019-00994-0. Epub 2019 Jul 26. Gastric Cancer. 2020. PMID: 31350702
-
Yield of Staging Laparoscopy for Incurable Factors in Chinese Patients with Advanced Gastric Cancer.J Laparoendosc Adv Surg Tech A. 2018 Jan;28(1):19-24. doi: 10.1089/lap.2017.0170. Epub 2017 Jun 26. J Laparoendosc Adv Surg Tech A. 2018. PMID: 28650730
-
The value of staging laparoscopy in gastric cancer.Ann Gastroenterol. 2017;30(3):287-294. doi: 10.20524/aog.2017.0133. Epub 2017 Mar 16. Ann Gastroenterol. 2017. PMID: 28469358 Free PMC article. Review.
-
The effects of staging laparoscopy on trocar site and peritoneal recurrence of pancreatic cancer.Surg Endosc. 2004 Feb;18(2):310-3. doi: 10.1007/s00464-003-8909-z. Epub 2003 Dec 29. Surg Endosc. 2004. PMID: 14691701 Review.
Cited by
-
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature.Ann Gastroenterol Surg. 2021 Feb 18;5(4):404-418. doi: 10.1002/ags3.12444. eCollection 2021 Jul. Ann Gastroenterol Surg. 2021. PMID: 34337289 Free PMC article. Review.
-
Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors.Cancers (Basel). 2021 Feb 2;13(3):582. doi: 10.3390/cancers13030582. Cancers (Basel). 2021. PMID: 33540736 Free PMC article. Review.
-
Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis.Front Oncol. 2022 Oct 28;12:955181. doi: 10.3389/fonc.2022.955181. eCollection 2022. Front Oncol. 2022. PMID: 36387230 Free PMC article.
-
Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective.Cancers (Basel). 2021 May 20;13(10):2509. doi: 10.3390/cancers13102509. Cancers (Basel). 2021. PMID: 34065596 Free PMC article. Review.
-
Machine learning-based prediction of gastroparesis risk following complete mesocolic excision.Discov Oncol. 2024 Sep 27;15(1):483. doi: 10.1007/s12672-024-01355-9. Discov Oncol. 2024. PMID: 39331201 Free PMC article.
References
-
- Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11:531–46. - PubMed
-
- Zaanana A, Bouchéb O, Benhaimc L, Buecher B, Chapelle N, Dubreuil O, et al. Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow‐up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2018;50:768–79. - PubMed
-
- Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) .Guidelines for Diagnostic Laparoscopy. 2010[Available at: https://www.sages.org/publications/guidelines/guidelines-for-diagnostic-...]. Accessed February 01, 2019.
-
- Scottish Intercollegiate Guidelines Network . Management of oesophageal and gastric cancer. Edinburgh, UK: Scottish Intercollegiate Guidelines Network; 2006.
-
- Shandall A, Johnson C. Laparoscopy or scanning in oesophageal and gastric carcinoma? Br J Surg. 1985;72(6):449–51. - PubMed
Publication types
LinkOut - more resources
Full Text Sources